FDA REFORM THIRD-PARTY PROVISIONS WILL BE AMENDED TO PREVENT REVIEW "SHOPPING" -- HOUSE COUNSEL; AGENCY CONTINUES TO ATTACK "RADICAL" HOUSE BILL
Executive Summary
FDA third-party review provisions will be amended in House legislation to alleviate concerns raised about direct negotiations between industry and outside reviewers, House Commerce Committee Counsel John Cohrssen indicated at a Food & Drug Law Institute meeting in Washington, D.C. May 13.